Skip to main content
CK Life Sciences Int'l., (Holdings) Inc. (HKG:0775)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.720
-0.010 (-1.37%)
Apr 29, 2026, 4:08 PM HKT

HKG:0775 Revenue

In the year 2025, CK Life Sciences Int'l., (Holdings) had annual revenue of 5.41B HKD, down -2.04%. CK Life Sciences Int'l., (Holdings) had revenue of 2.80B in the half year ending December 31, 2025, with 2.22% growth.

Revenue
5.41B
Revenue Growth
-2.04%
P/S Ratio
1.30
Revenue / Employee
2.82M
Employees
1,935
Market Cap
7.02B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20255.41B-112.45M-2.04%
Dec 31, 20245.52B199.94M3.76%
Dec 31, 20235.32B47.14M0.89%
Dec 31, 20225.28B-126.72M-2.35%
Dec 31, 20215.40B459.77M9.30%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Guangzhou Innogen Pharmaceutical Group 146.34M
Ocumension Therapeutics 895.09M
Laekna 118.76M
Jacobio Pharmaceuticals Group 59.56M
Abbisko Cayman 681.17M
Shanghai Haohai Biological Technology 2.73B
Lepu Biopharma 1.04B
Alphamab Oncology 630.11M
Revenue Rankings

CK Life Sciences Int'l., (Holdings) News

More News